CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop new antimicrobial therapies targeting Campylobacter jejuni and Salmonella serovars using bacteriophages. It focuses on identifying receptor binding proteins to enhance the effectiveness of these phage-derived treatments.
Campylobacter jejuni and Salmonella serovars are the major foodborne pathogen burden of Europe, imposing economic costs and challenging treatment of human infections due to increasing antimicrobial resistance.
Hence, the EU commission stresses an urgent need to develop new effective antimicrobials.
Exploiting natural predators of bacteria (phages) or phage-derived products may be a source of such novel antimicrobials.
But lack of genetic approaches to investigate phage binding mediated by recept…
KOBENHAVNS UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
